John R. Houk, Blog Editor
© October 18, 2021
Have you ever seen the movie “The Manchurian Candidate”?
For a little clarity The
Manchurian Candidate was first a 1959 novel, then a 1962 movie
and finally to date a 2004 movie remake. You will not it this way from the
Left-committed Wikipedia which I acquired the dates. NVERTHELESS, the movie (1962
is the best) is about how the Chinese Communist Party (CCP) and Communist
Soviets brainwashed captured American soldiers in the Korean War to be planted
back in the USA with a groomed to manipulate one of those soldiers to become
POTUS via Machiavellian politics and assassinations.
The CCP and Dem-Marxists are undergoing The Manchurian
Candidate experiment – QUITE SUCCESFULLY in my opinion – upon Americans with
COVID brainwashing to accept the will of the transformed Big Brother State
making Government-think the only reality.
Time is slipping away now seemingly daily for Americans to
reclaim the heritage our Founders initiated.
Below are two relatively recent articles followed by a few
videos awakens a few to refuse the brainwashing.
JRH 10/18/21
I need your generosity in 2021 via - credit cards, check
cards & debit cards are accepted by my PayPal account:
Or if not donating, you can support by getting in the Coffee from home
business earning yourself extra cash – OR just buy some TASTE GOOD healthy coffee,
that includes immune boosting products. Big Tech Censorship is pervasive –
Share voluminously on all social media platforms!
************************
COVID-19 Vaccine Facts Media Ignores, Part 3
By Roger
Anghis
October 17, 2021
Keep in mind that since the ‘vaccine’ came out they have
told us that it is 100% safe. Most reporting says the opposite but when people
don’t research anything all they do is believe what MSM is telling them. New
VAERS numbers should scare the daylights out of anyone who is considering
getting the jab. There have been 701,559 adverse events, 60,741
hospitalizations, 80,393 urgent care, 6,637 heart attacks, 5,765 myocarditis,
1,862 miscarriages, 19,210 disabled, and 14,925 deaths. More people have died
from the COVID ‘vaccine’ than all other deaths from all other vaccines
combined. Remember that these are just America’s numbers. In my last column, I
reported that the European Union has reported 26,041 deaths, 2,448,362
injuries.[1] Why is the government demanding that the whole planet gets the
‘vaccine’? It surely isn’t for our health as it seems we’d be a whole lot
healthier NOT taking the jab. You’ll also find out that any mention by MSM
about these adverse effects is not allowed. This administration does not want
the public to know about them.
It is being reported that in many places that there are high
numbers of COOVID patients who are fully vaccinated: Israel: “85-90%
of the hospitalizations are in fully vaccinated people”[2] Scotland:
70% of Covid deaths and 58% of hospitalizations are fully vaccinated.[3]
The illegals coming across our southern border are testing up to 20%
positive: Over 20 percent of illegal immigrant unaccompanied minors
and 18 percent of family units who recently crossed the U.S.-Mexico border have
tested positive for COVID-19 prior to being released from U.S. Customs and
Border Protection custody over the last several weeks, according to a
Department of Homeland Security document prepared for President Joe Biden
and reviewed
by NBC News Saturday.
The document also said some flights being used to
deport illegal immigrants had over 25 percent of the passengers test positive
before leaving, forcing Immigration and Customs Enforcement (ICE) to remove the
sick illegal immigrants and place them in quarantine.
“In the last 2-3 weeks, the percent positivity rates
among all demographics has increased,” the document says.[4] Biden
isn’t requiring them to get the ‘vaccine’ but he’s demanding that the border
patrol get it or get fired. Biden is also shipping the infected illegals
to red states with low numbers of cases. Tell me again Biden is demanding
people to get the jab for our health’s sake and I’ll have to call you a liar.
It’s more proof that the Democrats hate America and will do anything to bring
her down.
In an article from the Washington Post, there is a call for
anyone traveling from one state to another to show proof of vaccination. Requiring
vaccination for travel is hardly radical. The U.S. government has been
considering a mandate for people flying into the United States from foreign
countries. It’s already
required for Americans to fly internationally if
they don’t want to quarantine for 10 or more days in Germany, Britain, and
other destinations. These policies have allowed international travel to resume.
More than a month ago, Canada announced a
vaccine mandate for interprovincial travel on all forms of public transport. We
should follow our neighbor’s lead.
Such a mandate would be straightforward to create,
based on protecting federal employees from the infection risks created by
unvaccinated travelers. Transportation Security Administration staff are
exposed daily to thousands of unvaccinated people who pass through security
checkpoints.
Of course, there will be pushback. But cries of
“freedom” and “personal choice” are hollow and politically motivated. Our
freedom is not unlimited.[5] This sounds like 1930s Germany with
security checkpoints at the border. Notice that they mock our demand for
freedoms and personal choice.
Rand Paul questioned Xavier Becerra recently about the
science behind the ‘vaccine’ and Paul destroyed Becerra’s defense of demanding
everyone get the ‘vaccine’ with common sense but Becerra held to the left’s
narrative. Paul even stated that it was obvious that they were just demanding
that we comply and ask no questions. The following article, ‘Ignoring
the Science’: Sen. Rand Paul Exposes HHS Secretary Xavier Becerra for ‘Lying To
People About Natural Immunity’ for COVID-19, was first published
on Big League
Politics.
Sen. Rand Paul (R-KY) grilled
HHS Secretary Xavier Becerra on Thursday for “lying
to people about natural immunity” to COVID-19 as well as “ignoring science.”
“Mr. Becerra, are you familiar with an Israeli study
that had 2.5 million patients and found that the vaccinated group was actually
seven times more likely to get infected with Covid than the people who had
gotten Covid naturally?” Paul asked the health bureaucrat during a Senate
Health Committee hearing.
“I’m not familiar with that,” Becerra said in
response, feigning ignorance with the well-publicized study.
“I think you might want to be if you’re going to
travel the country insulting the millions of Americans, including NBA star
Jonathan Isaac, who had Covid, recovered, look at a study with 2.5 million
people, and say, well, you know what, I should make the decision. Instead,
you’ve called Jonathan Isaac and others, myself included, flat earthers,” Paul
clapped back. “We find that very insulting… Are you a doctor or a
medical doctor?” the liberty-loving senator asked.
“I have worked for over 30 years on health policy,”
Becerra said.
This is when Paul went in for the killshot on the paid
shill for Big Pharma.
“You’re not a medical doctor. Do you have a science
degree? And yet you travel the country, calling people flat earthers, who have
had Covid, looked at studies of millions of people, and made their own personal
decision that their immunity they naturally acquired is sufficient but you
presume somehow to tell over 100 million Americans who survived Covid that we have
no right to determine our own medical care,” Paul said.[6]
There is more and more evidence coming out that this is more
than a health issue. It is obvious that the left is making a power play to get
all the power they can. Even the Supreme Court is completely ignoring our
constitutional rights and their constitutional obligation. They ignored
their responsibility to review the evidence of voter fraud and on October 1st Sotomayor
denies New York school teachers the right to make medical decisions for themselves
about their own health. Supreme Court Justice Sonia Sotomayor has
denied a request by a group of New York City teachers to block the city’s
vaccine mandate for Department of Education staff.
Sotomayor did not request an additional briefing and also
did not refer the request to the full court.
As the Supreme Court Justice overseeing the Second
Circuit, Sotomayor has the discretion to address emergency applications on her
own.
Four New York Teachers had claimed in a petition that
a vaccine mandate had violated their right to due process and equal
protection.
The roughly 148,000 school employees in New York City
had until 5 p.m. Friday to get a least their first dose of the COVID-19
vaccination or face suspension without pay when schools open on Monday.[7]
The fourteen days to flatten the curve has turned into
almost twenty months with no end in sight, lockdowns, mask mandates, vaccine
mandates, and the loss of our right to work and shop unless we take what has
been proven to be a very dangerous gene therapy shot not a ‘vaccine’. If we
don’t stand now we won’t have that right in a very short time. The Democrats
will see to it.
© 2021 Roger Anghis – All Rights Reserved
E-Mail Roger Anghis: roger@buildingthetruth.org
Foot Notes
2. Israel-85-90-of-the-hospitalizations-are-in-fully-vaccinated-people
3. Scotland-70-of-covid-deaths-and-58-of-hospitalizations-are-fully-vaccinated
4. Illegal-immigrant-coming-into-us-have-covid-19-report-says
5. Biden-must-mandate-vaccines-travel
7. Justice
Sotomayor-denies-nyc-teachers-request-to-block-vaccine-mandate
Roger Anghis
is the Founder of BuildingtheTruth.org, an organization designed to draw
attention to the need of not just free speech for churches but disseminating
correct information through responsible journalism.
Copyright 2021 All Rights
Reserved NEWSWITHVIEWS.COM
++++++++++++++++++
US Set to Pay $712 per Patient for Merck’s COVID-19 Pill
Molnupiravir - Merck's antiviral against COVID-19 is seen in an
undated image. (Merck & Co. via AP)
October 16, 2021 Updated: October 17, 2021
Merck & Co. is set to receive $712 per treatment course
for its COVID-19 antiviral pill from the U.S. government—even as it costs a
fraction of that amount to produce and is reportedly on track for a price of
$12 in India.
The gap between production costs and the price for
molnupiravir is wide and emblematic of a problem that some say requires
Congress or the U.S. government to intervene by implementing price caps, or
utilizing so-called march-in rights. Others, though, warn that such measures
would curb innovation and lead to fewer drugs coming onto the market.
Merck filed for emergency use authorization from the
Food and Drug Administration for the oral drug last week, after it said an
interim analysis of trial data shows it cut hospitalizations in COVID-19
patients. An FDA advisory panel will consider the drug in November.
The treatment, a collection of pills given over five days,
would be the first of its kind since the pandemic started.
Originally developed by Emory
University with U.S. government funding, the drug was licensed by Ridgeback
Biotherapeutics last year. Efforts to win authorization during the Trump administration
were stymied, leading Ridgeback to turn to Merck.
Researchers this month pegged the cost of production for the
five-day treatment course at $17.74 (pdf) and estimated that Merck could make a sustainable
amount even if it priced a course as low as $19.99.
Melissa Barber of the Harvard T.H. Chan School of Public
Health and Dzintars Gotham of the King’s College Hospital used the cost of the
active pharmaceutical ingredient and other numbers to calculate the estimate.
The U.S. government committed last year to obtain 1.2
billion treatment courses if the drug received regulatory clearance. According
to a contract (pdf) obtained by Knowledge Ecology International, the
cost of each treatment would be $712.
“This price is equal to about 35 times the estimated
sustainable generic price,” Barber and Gotham said.
It’s also 46 times as much as Indian manufacturers plan to
charge for a generic version, according to Leena Menghaney, the South Asia head
of Médecins Sans Frontières’ Access Campaign.
“The molnupiravir case illustrates why the ‘TRIPS Waiver’ is
so urgently needed, which would waive intellectual property for COVID-19
medical tools during the pandemic and would remove legal barriers so that
countries the world over could produce versions of these medicines and more
lives could be saved,” she said in a statement, referring to a proposal to
waive intellectual property rights for COVID-19 vaccines and treatments.
Merck officials didn’t respond to requests for comment.
After public criticism of the cost of the company’s antiviral, an
executive, Dr. Nicholas Kartsonis, said the price it charged the U.S.
government isn’t the final figure.
“We set that price before we had any data, so that’s just
one contract,” Kartsonis told the Associated Press. “Obviously we’re going to
be responsible about this and make this drug as accessible to as many people
around the world as we can.”
Merck in a statement on Oct. 11 said it’s “committed to
providing timely access to molnupiravir globally, if it is authorized or
approved, and plans to implement a tiered pricing approach based on World Bank
country income criteria to reflect countries’ relative ability to finance their
health response to the pandemic.”
A logo of drugs and
chemicals group Merck
is pictured in Darmstadt, Germany, in a file photograph. (Ralph
Orlowski/Reuters)
Cheaper Than Other Treatments
While hydroxychloroquine and other drugs approved for
various afflictions but used as off-label COVID-19 treatments cost much less,
they aren’t recommended by federal authorities to treat COVID-19. The few
cleared as COVID-19 treatments cost more than Merck’s drug.
Remdesivir, the only approved treatment for hospitalized
patients, costs an estimated $5 (pdf) to produce and was sold to the U.S. government for $2,340 a
course—a price now pegged as too high for many patients. Monoclonal
antibody courses, used to treat mild or asymptomatic COVID-19 cases, cost
around $2,100 per course. The cost of production for the monoclonals isn’t
clear.
Merck’s drug “is lower than a lot of the other
treatments right now for COVID” and “certainly a lot cheaper in the United
States of ending up in a hospital,” James Love, director of Knowledge Ecology
International, told The Epoch Times.
“On the face of it, that doesn’t seem to be, initially, an
irresponsible pricing decision for Merck,” he said.
The average COVID-19 hospitalization costs $34,662 to
$45,683, according to data crunched by FAIR Health (pdf).
If regulators do find the drug safe—there are concerns it
could lead to the development of cancer—and authorize it in the United States,
the calculus could change.
“Suppose that a new variant ended up infecting a significant
percentage of the U.S. population and the drug was needed for 1 million, 10
million, or 50 million persons. At some point, the price just isn’t
reasonable,” Love said in an email.
Dr. Roger Klein, a health policy expert who currently
advises The Heartland Institute, doesn’t see the gap as a big deal, given that
developing treatments are “really high-risk endeavors” that cost a lot of
money, including millions of dollars just to run clinical trials.
“We don’t know how long these drugs are going to have a
market within the United States, which is the world’s most important drug market
in many ways,” he told The Epoch Times, adding that he believes the public
health crisis from the pandemic is close to being over because of an increasing
number of people gaining immunity through vaccination or prior infection.
Every treatment costs much more than vaccines. The shots
have all been priced under $20 a dose, according to contracts between vaccine
makers and the U.S. government.
A sign is posted in front
of Gilead
Sciences headquarters in Foster City, Calif., on April 29, 2020.
(Justin Sullivan/Getty Images)
March-in Rights
One possible approach to lowering drug prices is utilizing
various provisions of the Bayh–Dole Act of 1980, some experts say.
The act let the federal government retain some rights for
inventions produced with government funding. It also enables federal agencies
to use known as march-in rights, through which the government in certain
circumstances can require a company to grant a license for a drug to an
applicant. The government can grant the license itself if the patent owner
refuses.
Some experts and advocates say march-in rights can be used
to ease drug prices or provide leverage in negotiations on prices.
Thirty-one state attorneys general called last year on the
federal government to exercise march-in rights on remdesivir to boost supply
and lower its price.
“Here, we think it is clear that Gilead has not established
a reasonable price, nor has it met the health and safety needs of the public
given the COVID-19 pandemic,” they wrote (pdf).
However, no federal agency has ever exercised the power,
according to the Congressional Research Service and opponents say the law has
only narrow application.
The National Institutes of Health (NIH) has said multiple
times the act doesn’t authorize it to set prices, Dr. Mark Rohrbaugh,
special adviser for technology transfer at the NIH, said during a panel
discussion last year held by the Bayh–Dole 40 Coalition and Information
Technology and Innovation Foundation. No other federal agency has disagreed
with this position, he said.
Both the Trump and Biden administrations have rebuffed those
calls and other efforts to cap prices during the pandemic.
“We can’t control that price because we need the private
sector to invest,” Alex Azar, the health secretary at the time, said during a
congressional hearing in February 2020.
Even if march-in rights can’t be used, the government can
negotiate prices, others say.
The government’s funding and involvement with setting
contracts with hospitals for remdesivir should have led to price
concessions, Dr. Peter Bach, director of the Center for Health Policy and
Outcomes at the Memorial Sloan Kettering Cancer Center, said during an
Institute for Clinical and Economic Review (ICER) panel discussion last year.
Public Citizen, an advocacy group, has urged the Biden
administration to use executive authority to impose “a reasonable pricing
requirement” so that “taxpayers don’t pay twice for medicine developed with
public funds—first funding research and development, and again through
excessive prices.”
Gilead and Eli Lilly, which produces monoclonals, did not
respond to requests for comment. A GlaxoSmithKline spokeswoman declined to
provide information on the cost of production for the antibodies. A Regeneron
spokesman told The Epoch Times in an email that monoclonals
“are complex to develop and manufacture, requiring time, specialized
facilities and expertise, hence the higher cost of this class vs. vaccines.”
“Monoclonal antibodies are intended primarily as treatment,
and so also have cost-effectiveness in being administered only to high-risk
patients who are otherwise likely to be hospitalized, as opposed to vaccines
which are intended to be administered to all,” he added.
A Regeneron
monoclonal antibody infusion bag is seen during a news conference in
Fort Lauderdale, Fla., on Aug. 19, 2021. (Joe Cavaretta/South Florida
Sun-Sentinel via AP)
Quest to Revamp Pricing
Prices can vary based on a number of factors, Merck says in
a fact sheet, including value to patients and health care systems and the
investment into research and development.
Other factors include what the market is willing to pay and
the number of alternatives, according to Joey Mattingly, associate
professor and vice chair of academic affairs at the University of Maryland
School of Pharmacy’s Department of Pharmaceutical Health Services Research. The
volume of sales also plays a role, as do getting large contracts from
governments.
Drugmakers have long been accused of charging too much for
products, especially drugs for rare diseases. Some experts and lawmakers have
pushed to revamp the drug pricing system, but the issue has bedeviled Congress
since the 1950s.
An agreement was close in the 1960s on a proposal by
then-Sen. Estes Kefauver (D-Tenn.) to implement pricing caps and other ideas
currently supported among some members of both parties. But Kefauver couldn’t
ultimately secure enough votes, and the Kefauver–Harris Amendment that
eventually passed focused primarily on drug safety and efficacy.
“There’s a lot of proposals out there, good or bad, and
we’ll just see if it has the votes and the things that don’t have the votes
will fall out and we’ll keep talking about it and then depending on how
elections go over the next 10 years, maybe there will [be a change], but I’m
not holding my breath, just because I know we’ve been on this journey for 60
years,” Mattingly said.
Zachary Stieber covers U.S.
news, including politics and court cases. He started at The Epoch Times as a
New York City metro reporter.
Copyright © 2000 – 2021 The Epoch Times
+++++++++++++++++++++++++++++
Blog Editor: Here are two important videos I found via subscribing
to Geri Ungurean’s blog Absolute
Truth from the Word of God. As a Hat Tip here’s the title she used:
Glazov
Gang : HORROR “Vaccine” VIALS Under the Microscope: Vera Sharav: COVID Vaccine
Mandates & NAZI Tactics “Auschwitz did not begin with Auschwitz.” THE
HORRIFIC TRUTH Finally Being Unveiled and the TRUTH is SCARIER than Any HORROR
MOVIE Ever Made (VIDEOS). Lengthy title to a couple of informative
videos based on science and experience Dem-Marxist controller/propagandists
just as soon you NOT watch.
Rumble VIDEO: Horror:
Covid ‘Vaccine’ Vials Under the Microscope.
Posted by The
Glazov Gang
Published October 15, 2021
Horror: Covid ‘Vaccine’ Vials Under the Microscope.
Dr. Carrie Madej (Osteopathic Internal Medicine Physician)
++++++++++++++++++++
Rumble VIDEO: Holocaust
Survivor on Covid Vaccine Mandates & Nazi Tactics
Posted by The
Glazov Gang
Published October 2, 2021
Vera Sharav (Founder, Alliance for Human Research
Protection)
No comments:
Post a Comment